Laura,
You should receive the info for the webinar after you register.
Rest of post
On Mon, Dec 14, 2020 at 10:17 AM Bover,Laura <email obscured>> wrote:
> Hi David I registered already. How will we access the webinar?
>
> Laura Bover, PhD
> (working from home during COVID-19 Cell 713-703-1951<tel:713-703-1951>)
> Professor
> Director Monoclonal Antibody Core Facility
> University of Texas M.D.Anderson Cancer Center
> Associate member of The University of Texas Graduate School of Biomedical
> Sciences at Houston
> Member of the Scientific Review Committee 2 (former Clinical Research
> Committee 2)
> Member of the Steering Committee of the Immunology Program GSBS
> Immunology Department/ Genomics Medicine Department
> 7455 Fannin St<x-apple-data-detectors://2/1> Room 1SCR4.2021
> Houston- TX 77054<x-apple-data-detectors://3/0>
> T 713-563-3301<tel:713-563-3301>
> F 713-563-3276<tel:713-563-3276>
> <email obscured><email obscured>>
>
> In order to continue obtaining Core support in a challenging environment,
> it is crucial that our users acknowledge the following grants in all
> publications (see following text). Thank you!
> “We acknowledge the UT-MDACC Monoclonal Antibodies Core facility,
> supported in part by CCSG grant number P30 CA016672.”
>
> Sent from my iPhone
>
> On Dec 14, 2020, at 8:16 AM, David Blum <email obscured>> wrote:
>
> WARNING: This email originated from outside of MD Anderson. Please
> validate the sender's email address before clicking on links or attachments
> as they may not be safe.
>
> There is still time to register for the webinar this morning at 11am. We
> are also looking for speakers for next year. Please contact me if you
> would like to speak or are willing to invite a speaker.
>
> Antibody Technology Interest Network Presentation:
> The Link between T Follicular Helper Responses and Neutralizing Antibody
> and Memory B Cell Responses to SARS-CoV-2
> Monday, December 14, 2020 11:00 a.m.–12:00 p.m. ET
>
> Register here
> <
>
https://urldefense.com/v3/__https://us02web.zoom.us/meeting/register/tZEld-yqqj4oGtVYWVL_exfgItEG-6GfKrMo__;!!PfbeBCCAmug!0FaRI1ju5IqkEEQ021tPxW6JLr-sG4E9PJpUG_QoBLLh9hy859fGJ22kdNdX2W2j$
> >
>
> ――
> View topic
>
https://urldefense.com/v3/__http://list.abrf.org/r/topic/5Qd6hb0c9gVeAVYxISQQOf__;!!PfbeBCCAmug!0FaRI1ju5IqkEEQ021tPxW6JLr-sG4E9PJpUG_QoBLLh9hy859fGJ22kdPVsr1nx$
> Leave group <email obscured>?Subject=Unsubscribe
>
> The information contained in this e-mail message may be privileged,
> confidential, and/or protected from disclosure. This e-mail message may
> contain protected health information (PHI); dissemination of PHI should
> comply with applicable federal and state laws. If you are not the intended
> recipient, or an authorized representative of the intended recipient, any
> further review, disclosure, use, dissemination, distribution, or copying of
> this message or any attachment (or the information contained therein) is
> strictly prohibited. If you think that you have received this e-mail
> message in error, please notify the sender by return e-mail and delete all
> references to it and its contents from your systems.
>
> ――
> View topic http://list.abrf.org/r/topic/7v0YX5vmhZUVMBr2rCj3b9
> Leave group <email obscured>?Subject=Unsubscribe
>
>